Canadian Nephrologist Views Regarding Stroke and Systemic Embolism Prevention in Dialysis Patients With Nonvalvular Atrial Fibrillation: A Survey.

ABSTRACT:

Background

Nonvalvular atrial fibrillation (NVAF) is an independent risk factor for ischemic stroke and is common in chronic kidney disease (CKD) and dialysis patients. The use of oral anticoagulation to prevent stroke and systemic embolism in the setting of kidney disease is controversial. Novel alternatives to vitamin K antagonists include left atrial appendage occlusion devices (LAAOD) and apixaban.

Objective

We sought to elicit Canadian nephrologist views regarding stroke and systemic embolism prevention therapies in CKD and dialysis patients with NVAF.

Design

Survey.

Setting

Online via https://www.surveymonkey.com.

Participants

Canadian Society of Nephrology members actively treating adult dialysis patients with NVAF.

Measurements

Management

SUBMITTER: Collister D 

PROVIDER: S-EPMC6327328 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature